✦ LIBER ✦

Radioiodine-induced changes in lymphocyte subsets in patients with differentiated thyroid carcinoma

✍ Scribed by Anna Tofani; Rosa Sciuto; Raffaele P. Cioffi; Rosella Pasqualoni; Sandra Rea; Anna Festa; Giuseppe M. Gandolfo; Maria C. Arista; Carlo L. Maini

Publisher: Springer
Year: 1999
Tongue: English
Weight: 117 KB
Volume: 26
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s002590050455

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postsurgical thyroid remnant estimation

Postsurgical thyroid remnant estimation by 99mTc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma

✍ Luca Giovanella; Sergio Suriano; Riccardo Ricci; Luca Ceriani; Frederik Anton Ve 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

## Abstract ## __Background.__ The purpose of this study was to evaluate the relationship between postsurgical neck ^99m^technetium (^99m^Tc)‐pertechnetate uptake and the rate of successful remnant ablation after radioiodine treatment in patients with differentiated thyroid carcinoma (DTC). ## __

Respiratory distress caused by radioiodi

Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer

✍ Seigo Kinuya; Kunihiko Yokoyama; Takatoshi Michigishi; Norihisa Tonami 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 982 KB

Prognostic factors in patients with recu

Prognostic factors in patients with recurrent differentiated thyroid carcinoma

✍ Asakawa, Hideki; Kobayashi, Tetsuro; Komoike, Yoshifumi; Tamaki, Yasuhiro; Matsu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 3 views

Background: Approximately 20% of patients with thyroid carcinoma have relapse. To evaluate the factors affecting their disease-free survival and prognosis, we studied 68 patients with recurrent differentiated thyroid carcinoma, ranging in age from 5 to 73 years (mean: 47.6 years). Threefourths of pa

Recurrence-associated mortality in patie

Recurrence-associated mortality in patients with differentiated thyroid carcinoma

✍ Dr. Yodphat Krausz; Beatrice Uziely; Haim Karger; Ruth Isacson; Raphael Catane; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

## Abstract Differentiated thyroid carcinoma (DTC) is associated with prolonged natural history, and even recurrent tumor is not necessarily followed by increased mortality. Prognostic factors and different treatment strategies, therefore, are difficult to assess. One hundred and fifty‐seven patien

Why should the radioiodine dose be diffe

Why should the radioiodine dose be different in patients with differentiated thyroid carcinoma prepared with recombinant human TSH?

✍ Fabián Pitoia; OsvaldoJ. Degrossi; Hugo Niepomniszcze 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 101 KB

Diagnosis of neck recurrences in patient

Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma

✍ Andrea Frasoldati; Marialaura Pesenti; Marco Gallo; Angelo Caroggio; Diana Salvo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 1 views

## Abstract ## BACKGROUND The follow‐up of patients with differentiated thyroid carcinoma (DTC) is traditionally carried out with ^131^I whole body scan (^131^I WBS) and serum thyroglobulin (Tg) measurement. Neck ultrasonography (US) is also used. ## METHODS We compared the roles of Tg measureme